The Patent Finder

Ixchelsis Limited

Also on record
Records under this name other than patents Ixchelsis Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Ixchelsis Limited

PatentTitleStatus Expires Confidence
US 7,557,131Substituted Triazole Derivatives as Oxytocin Antagonists
Term ended
Term ended Jun 17, 2026 · High confidence
Term endedTerm ended Jun 17, 2026High confidence
US 9,023,872Substituted Triazole Derivatives as Oxytocin Antagonists
Term ended
Term ended Jan 20, 2026 · High confidence
Term endedTerm ended Jan 20, 2026High confidence
US 10,150,752Substituted Triazole Derivatives as Oxytocin Antagonists
Term ended
Term ended Jan 20, 2026 · Medium confidence
Term endedTerm ended Jan 20, 2026Medium confidence
US 9,394,278Substituted Triazole Derivatives as Oxytocin Antagonists
Lapsed on the fee record
Ended Jul 19, 2024 · High confidence
Lapsed on the fee recordEnded Jul 19, 2024High confidence
US 8,207,198Substituted Triazole Derivatives as Oxytocin Antagonists
Lapsed on the fee record
Ended Jun 26, 2024 · High confidence
Lapsed on the fee recordEnded Jun 26, 2024High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited